Developing new drug formulations for clinical trials
ALBANY MOLECULAR RESEARCH, INC(AMRI)[19-002417]MCSP TASK ORDER XU PROJECT - EXPLORATORY CHEMISTRY POP: TBD
This study is all about creating new medicines that could help patients by making sure they are safe and effective before they are tested in clinical trials.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Albany Molecular Research, INC. NIH-funded |
| Lab location | 1 site (Albany, United States) |
| Project ID | NIH-10031075 on NIH RePORTER |
What this research studies
This research focuses on the development and manufacturing of new drug formulations that are suitable for clinical trials. It involves creating small molecule drug candidates and ensuring they meet regulatory standards for safety and efficacy. The process includes various stages such as formulation studies, analytical method development, and compliance with Good Manufacturing Practices (cGMP). Patients may benefit from new medications that emerge from this rigorous development process.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit are individuals with conditions that could be treated by the new drugs being developed.
Not a fit: Patients who are not affected by the conditions targeted by the new drug formulations may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of new and effective medications for various conditions.
How similar studies have performed: Previous research within the Blueprint Neurotherapeutics Network has shown success in accelerating drug development processes.
Where this research is happening
Albany, United States
- Albany Molecular Research, INC. — Albany, United States (Active)
Researchers
- Principal investigator: Allard, Melissa — Albany Molecular Research, INC.
- Study coordinator: Allard, Melissa
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.